Treatment options
- 1 November 2002
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 203-204, 125-130
- https://doi.org/10.1016/s0022-510x(02)00267-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trialBMJ, 2000
- Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's diseaseEuropean Journal of Pharmacology, 2000
- An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factorsEuropean Journal of Neurology, 2000
- Prevalence and outcomes of vascular cognitive impairmentNeurology, 2000
- Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats.Neuroscience Letters, 1999
- Overlap Between Pathology of Alzheimer Disease and Vascular DementiaAlzheimer Disease & Associated Disorders, 1999
- Use of Donepezil for Vascular DementiaThe Journal of Neuropsychiatry and Clinical Neurosciences, 1999
- Cerebrovascular DementiaCNS Drugs, 1999
- Worldwide Prevalence and Incidence of DementiaDrugs & Aging, 1999
- Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996